Rb and p16 expression in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Flieder, DB
Brambilla, E
Rush, W
Przygodzki, R
Fleming, M
Freedman, A
Travis, W
Caporaso, N
Guinee, D
Bennett, W
Jones, R
Trastek, V
Pairolero, P
Tazelaar, H
Jett, J
Midthun, D
Liotta, L
Harris, CC
机构：
[1] NCI, Human Carcinogenesis Lab, Bethesda, MD 20892 USA
[2] NCI, Genet Epidemiol Branch, Bethesda, MD 20892 USA
[3] CHRU, Pathol Cellulaire Lab, Grenoble, France
[4] AFIP, Washington, DC USA
[5] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA
[6] Mayo Clin, Rochester, MN USA
来源：
MODERN PATHOLOGY | 1998年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：173A / 173A
页数：1
相关论文
共 50 条
  • [1] P16 methylation and protein expression in non-small cell lung cancer
    Aviel-Ronen, Sarit
    Ling, Chunhua
    Lu, Ming
    Lau, Davina
    Ho, James
    Liu, Ni
    Tsao, Mingsound
    MODERN PATHOLOGY, 2006, 19 : 163 - 163
  • [2] Rb and p16(INK4a) expression in resected non-small cell lung tumors
    Kratzke, RA
    Greatens, TM
    Rubins, JB
    Maddaus, MA
    Niewoehner, DE
    Niehans, GA
    Geradts, J
    CANCER RESEARCH, 1996, 56 (15) : 3415 - 3420
  • [3] p16 expression and survival in non-small cell lung cancer: Analysis of 414 cases
    Coffey, DM
    Castro, CY
    Gondo, MM
    Stephenson, MA
    Brown, RW
    Lebovitz, RM
    Cagle, PT
    LABORATORY INVESTIGATION, 1997, 76 (01) : 949 - 949
  • [4] Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: An immunohistochemical study
    Sakaguchi, M
    Fujii, Y
    Hirabayashi, H
    Yoon, HE
    Komoto, Y
    Oue, T
    Kusafuka, T
    Okada, A
    Matsuda, H
    INTERNATIONAL JOURNAL OF CANCER, 1996, 65 (04) : 442 - 445
  • [5] Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer
    Cheng, YL
    Lee, SC
    Harn, HJ
    Chen, CJ
    Chang, YC
    Chen, JC
    Yu, CP
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (02) : 221 - 228
  • [6] Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers
    Kashiwabara, K
    Oyama, T
    Sano, T
    Fukuda, T
    Nakajima, T
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (03) : 215 - 220
  • [7] Decreased expression of p16 and p27 in non-small cell lung carcinoma (NSCLC) associated with unfavorable clinical outcome.
    Al-Salameh, SAA
    Ryes, L
    Ramnath, N
    Anderson, T
    Tan, D
    MODERN PATHOLOGY, 2001, 14 (01) : 216A - 216A
  • [8] Detection of p16 abnormalities in early-stage non-small, cell lung cancer
    Niklinska, W
    Chyczewski, L
    Laudanski, J
    Chyczewska, E
    Niklinski, J
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 : 30 - 32
  • [9] P16 Methylation Leads to Paclitaxel Resistance of Advanced Non-Small Cell Lung Cancer
    Liu, Zhaojun
    Lin, Hongmei
    Gan, Ying
    Cui, Chenghua
    Zhang, Baozhen
    Gu, Liankun
    Zhou, Jing
    Zhu, Guangying
    Deng, Dajun
    JOURNAL OF CANCER, 2019, 10 (07): : 1726 - 1733
  • [10] Expression of P16 and Detection of Subtypes of HPV RNA in Primary Non-Small Cell Lung Cancers (NSCLC) and Their Potential Clinical Implication
    Kharajian, Armen
    Ma, Xiao-Jun
    Zhang, Zhen
    Askin, Frederic
    Gabrielson, Edward
    Luo, Yuling
    Li, Qing Kay
    MODERN PATHOLOGY, 2016, 29 : 473A - 473A
12345